PROTEOMICS MARKET ANALYSIS

Proteomics is a study of large scale proteomes. Proteomes are entire complements of protein expressed by a tissue, cell or organism. Proteomics aims to interpret the roles of large number of proteins made from combining 22 genetically-encoded amino acids. It helps to understand the structure, function, and interactions of the entire protein content in a specific organism. It is used to investigate protein expression, rates of protein production, degradation, modification of protein, protein movements in subcellular compartments, and protein-protein interaction.

Global Proteomics Market: Drivers

Key players in the market are focused on introducing new and improved proteomics techniques, which is expected to boost the proteomics market growth. For instance, in September 2017, Bruker Corporation launched timsTOF Pro system for parallel accumulation and serial fragmentation (PASEF) mass spectrometry— using proprietary trapped ion mobility spectrometry (TIMS) technology—to offer efficient data acquisition speed for shotgun proteomics.

Moreover, in October 2018, Bruker Corporation introduced a next-generation workflow for the timsTOF Pro mass spectrometer at Human Proteome Organization (HUPO). The platform for timsTOF Pro workflow includes large-scale, reproducible, and accurate collision cross section (ccs) values for tryptic peptides, fastpro, and ccs-based lipidomics workflow.

Moreover, in 2017, Diagenode, a provider of complete solutions for epigenetics research and sample preparation, in collaboration with PreOmics GmbH, developer and provider of innovative tools for MS-based proteomics, launched new streamlined sample preparation solution for proteomic analyses. The new solution was developed by combining PreOmics in-StageTip Kit (iST Kit) and the Diagenode Bioruptor sonication system to clean peptides for mass spectrometry (MS) analysis.

Global Proteomics Market: Regional Analysis

On the basis of region, the global proteomics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to account for the largest market share in the proteomics market over the forecast period. The market growth is attributed to increasing collaboration and partnership activities by key players in this region. For instance, in November 2018, Thermo Fisher Scientific Inc. and Symphogen entered into a two-year collaborative partnership to deliver validated platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. Under this agreement, Symphogen would have access to Thermo Fisher’s Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC-MS/MS) system with BioPharma Option for creating, testing, and validating the platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures. Moreover, Symphogen will focus on the development of automated multi-attribute method (MAM) workflows for monitoring critical quality attributes of proteins using high-resolution accurate-mass mass spectrometry in a quality control environment.

Increasing government initiatives to promote research and development in proteomics, genomics, and bioinformatics is expected to propel Asia Pacific proteomics market growth during the forecast period. For instance, the 13th International Conference on Proteomics, Genomics, and Bioinformatics will be held on May 10-11, 2019 in Tokyo, Japan. The theme of the conference will be ‘Leading Edge Innovations in Life Sciences’ and the objective will be to explore the recent advancements and new methodologies that can be applied to the research to make proteomics and bioinformatics more advance. Target audience for the upcoming conference can be health professionals, researchers and scientists, management/business leaders and/or agents, government/non-government community groups or individuals, professors, psychiatrist, and therapists.

Key players operating in the global proteomics market include, Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics Inc., PerkinElmer, Inc., Biognosys Inc., Bruker, Cell Signaling Technology, Inc., Newomics, Inc., Proteome Sciences, Applied Biomics, Inc., Courtagen Life Sciences, Inc., Xcelris Genomics., Center for Genomic Sciences, and Sera Prognostics, Inc.

Global Proteomics Market Taxonomy

By Product Type

• Reagents and Kits
  • Microarray
  • Spectroscopy
  • X-ray Crystallography
  • Chromatography
  • Electrophoresis
  • Immunoassay
  • Protein Fractionation Reagents
• Instruments
  • Protein Microarray
  • Spectrometry
    • Mass Spectrometry
    • NMR Spectroscopy
  • Chromatography
    • HPLC Systems
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Surface Plasmon Resonance
  • X-ray Crystallography
  • Protein Fractionation Systems

By Application

• Drug Discovery
• Clinical Diagnosis
• Molecular Medicine
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa